Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Elisabeth Ejerblad, Hans M. Kvasnicka, Jürgen Thiele, Björn Andreasson, Magnus Björkholm, Eva Löfvenberg, Berit Markevärn, Mats Merup, Lars Nilssson, Jan Palmblad, Jan Samuelsson & Gunnar Birgegård. (2013) Diagnosis according to World Health Organization determines the long-term prognosis in patients with myeloproliferative neoplasms treated with anagrelide: Results of a prospective long-term follow-up. Hematology 18:1, pages 8-13.
Read now
Read now
Juergen Thiele & Hans M. Kvasnicka. (2006) A critical reappraisal of the WHO classification of the chronic myeloproliferative disorders. Leukemia & Lymphoma 47:3, pages 381-396.
Read now
Read now
Tİmucİn Aydogan, Mehmet Kanbay, Ozlem Alİcİ & Alİ Kosar. (2006) Incidence and etiology of thrombocytosis in an adult Turkish population. Platelets 17:5, pages 328-331.
Read now
Read now
Anita Ryningen, Torunn Apelseth, Trygve Hausken & Øystein Bruserud. (2006) Reticulated platelets are increased in chronic myeloproliferative disorders, pure erythrocytosis, reactive thrombocytosis and prior to hematopoietic reconstitution after intensive chemotherapy. Platelets 17:5, pages 296-302.
Read now
Read now
Tadeusz Robak, Halina Urbańska-Ryś, Joanna Góra-Tybor, Ewa Wawrzyniak, Anna Korycka, Jacek Bartkowiak, Radzisław Kordek & Aaron Polliack. (2003) Coexistence of Chronic Lymphocytic Leukemia and Essential Thrombocythemia. Leukemia & Lymphoma 44:8, pages 1425-1431.
Read now
Read now
BjÖRn Andréasson, GÖRan Lindstedt, Dick Stockelberg, Hans Wadenvik & Jack Kutti. (2001) The Relation Between Plasma Thrombopoietin and Erythropoietin Concentrations in Polycythaemia Vera and Essential Thrombocythaemia. Leukemia & Lymphoma 41:5-6, pages 579-584.
Read now
Read now
BjÖRn Andréasson, GÖRan Lindstedt & Jack Kutti. (2000) Plasma Erythropoietin in Essential Thrombocythaemia: at Diagnosis and in Response to Myelosuppressive Treatment. Leukemia & Lymphoma 38:1-2, pages 113-120.
Read now
Read now
Juergen Thiele, Hans Michael Kvasnicka, Volker Diehl, Robert Fischer & Jan Jacques Michiels. (1999) Clinicopathological Diagnosis and Differential Criteria of Thrombocythemias in Various Myeloproliferative Disorders by Histopathology, Histochemistry and Immunostaining from Bone Marrow Biopsies. Leukemia & Lymphoma 33:3-4, pages 207-218.
Read now
Read now
Articles from other publishers (40)
Nuria Gómez-Cebrián, Ayelén Rojas-Benedicto, Arturo Albors-Vaquer, Beatriz Bellosillo, Carlos Besses, Joaquín Martínez-López, Antonio Pineda-Lucena & Leonor Puchades-Carrasco. (2021) Polycythemia Vera and Essential Thrombocythemia Patients Exhibit Unique Serum Metabolic Profiles Compared to Healthy Individuals and Secondary Thrombocytosis Patients. Cancers 13:3, pages 482.
Crossref
Crossref
M. Mohamud, L. Osborne, H. G. Jones, A. Ahmed, J. Beynon, D. A. Harris, M. Evans, M. Davies, U. Khot & T. V. Chandrasekaran. (2018) Thrombocytosis as a Marker for Postoperative Complications in Colorectal Surgery. Gastroenterology Research and Practice 2018, pages 1-5.
Crossref
Crossref
Magnus BjörkholmÅsa R. DerolfMalin HultcrantzSigurdur Y. KristinssonCharlotta EkstrandLynn R. GoldinBjörn AndreassonGunnar BirgegårdOlle LinderClaes MalmBerit MarkevärnLars NilssonJan SamuelssonFredrik GranathOla Landgren. (2011) Treatment-Related Risk Factors for Transformation to Acute Myeloid Leukemia and Myelodysplastic Syndromes in Myeloproliferative Neoplasms. Journal of Clinical Oncology 29:17, pages 2410-2415.
Crossref
Crossref
DANIEL A. ARBER. 2009. Modern Surgical Pathology. Modern Surgical Pathology
1536
1593
.
Ola LandgrenLynn R. GoldinSigurdur Y. KristinssonElin A. HelgadottirJan Samuelsson & Magnus Björkholm. (2008) Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24 577 first-degree relatives of 11 039 patients with myeloproliferative neoplasms in Sweden. Blood 112:6, pages 2199-2204.
Crossref
Crossref
Victor E. Valli. 2007. Veterinary Comparative Hematopathology. Veterinary Comparative Hematopathology
425
460
.
Magnus Hultdin, Gunnel Sundström, Anders Wahlin, Berith Lundström, Jan Samuelsson, Gunnar Birgegård & Anna Engström-Laurent. (2007) Progression of bone marrow fibrosis in patients with essential thrombocythemia and polycythemia vera during anagrelide treatment. Medical Oncology 24:1, pages 63-70.
Crossref
Crossref
Hans Michael Kvasnicka & Jürgen Thiele. (2007) Classification of Ph-Negative Chronic Myeloproliferative Disorders – Morphology as the Yardstick of Classification. Pathobiology 74:2, pages 63-71.
Crossref
Crossref
Christof Dame. 2006. Pediatric Hematology. Pediatric Hematology
548
561
.
Ramesh Balasubramaniam, Joseph Van Sickels & Donald Falace. (2006) Condylar resorption following temporomandibular joint arthroscopy in a patient with essential thrombocythemia. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 101:5, pages 581-587.
Crossref
Crossref
Takeshi MIZUKOSHI, Yasuhito FUJINO, Kuniyoshi YASUKAWA, Hidefumi MATUMOTO, Shingo MATSUMURA, Teppei NAGASAKI, Koichi OHNO, Hajime TSUJIMOTO & Tetsuya SHIMODA. (2006) Essential Thrombocythemia in a Dog. Journal of Veterinary Medical Science 68:11, pages 1203-1206.
Crossref
Crossref
J. Brière. (2006) Thrombocytémie essentielle. Critères du diagnostic. Stratification pronostique. Ébauche de stratégie thérapeutique. EMC - Hématologie 1:3, pages 1-19.
Crossref
Crossref
U. Schuler & G. Ehninger. 2006. Kompendium Internistische Onkologie. Kompendium Internistische Onkologie
2749
2775
.
Rubén Peredo, Salvador Vilá, Michelle Goñi, Edgar Colón & Grissel Ríos-Solá. (2005) Reactive Thrombocytosis. JCR: Journal of Clinical Rheumatology 11:5, pages 270-273.
Crossref
Crossref
Yasmine Chait, Bertrand Condat, Dominique Cazals-Hatem, Pierre Rufat, Sai Atmani, Driss Chaoui, Françoise Guilmin, Jean Jacques Kiladjian, Aurélie Plessier, Marie Hélène Denninger, Nicole Casadevall, Dominique Valla & Jean B. Brière. (2005) Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis. British Journal of Haematology 129:4, pages 553-560.
Crossref
Crossref
Christof Dame & Anton Heinz Sutor. (2005) Primary and secondary thrombocytosis in childhood. British Journal of Haematology 129:2, pages 165-177.
Crossref
Crossref
P. Johansson, J. Kutti, B. Andreasson, S. Safai-Kutti, L. Vilen, H. Wedel & B. Ridell. (2004) Trends in the incidence of chronic Philadelphia chromosome negative (Ph-) myeloproliferative disorders in the city of Goteborg, Sweden, during 1983-99. Journal of Internal Medicine 256:2, pages 161-165.
Crossref
Crossref
Peter Johansson, Anne Ricksten, Lovisa Wennström, Lars Palmqvist, Jack Kutti & Björn Andréasson. (2003) Increased risk for vascular complications in PRV-1 positive patients with essential thrombocythaemia. British Journal of Haematology 123:3, pages 513-516.
Crossref
Crossref
Tracy I George & Daniel A Arber. (2003) Pathology of the myeloproliferative diseases. Hematology/Oncology Clinics of North America 17:5, pages 1101-1127.
Crossref
Crossref
Peter Johansson, Björn Andréasson, Soodabeh Safai-Kutti, Lovisa Wennström, Lars Palmqvist, Anne Ricksten, Göran Lindstedt & Jack Kutti. (2003) The presence of a significant association between elevated PRV-1 mRNA expression and low plasma erythropoietin concentration in essential thrombocythaemia. European Journal of Haematology 70:6, pages 358-362.
Crossref
Crossref
Michael G. Alexandrakis, Freda H. Passam, Ioanna A. Moschandrea, Anna V. Christophoridou, Constantina A. Pappa, Stavroula A. Coulocheri & Despina S. Kyriakou. (2003) Levels of Serum Cytokines and Acute Phase Proteins in Patients With Essential and Cancer-Related Thrombocytosis. American Journal of Clinical Oncology 26:2, pages 135-140.
Crossref
Crossref
J. Thiele & H. M. Kvasnicka. (2003) Chronic myeloproliferative disorders with thrombocythemia: a comparative study of two classification systems (PVSG, WHO) on 839 patients. Annals of Hematology 82:3, pages 148-152.
Crossref
Crossref
L Florensa, L Zamora, C Besses, JJ Ortega, P Bastida, T Toll, P Mayayo, B Espinet, F Solé, S Serrano & S Woessner. (2002) Cultures of myeloid progenitor cells in pediatric essential thrombocythemia. Leukemia 16:9, pages 1876-1877.
Crossref
Crossref
Jan Jacques Michiels & Juergen Thiele. (2002) Clinical and Pathological Criteria for the Diagnosis of Essential Thrombocythemia, Polycythemia Vera, and Idiopathic Myelofibrosis (Agnogenic Myeloid Metaplasia). International Journal of Hematology 76:2, pages 133-145.
Crossref
Crossref
Juergen Thiele, Hans Michael Kvasnicka, Annette Schmitt‐Graeff, Rudolph Zankovich & Volker Diehl. (2002) Follow‐up examinations including sequential bone marrow biopsies in essential thrombocythemia (ET): A retrospective clinicopathological study of 120 patients. American Journal of Hematology 70:4, pages 283-291.
Crossref
Crossref
Björn Andréasson, Birgitta Swolin & Jack Kutti. (2002)
Patients with idiopathic myelofibrosis show increased CD34
+
cell concentrations in peripheral blood compared to patients with polycythaemia vera and essential thrombocythaemia
. European Journal of Haematology 68:4, pages 189-193.
Crossref
Crossref
Tiziano Barbui. (2002) What is the standard treatment in essential thrombocythemia. International Journal of Hematology 76:S2, pages 311-317.
Crossref
Crossref
Ruben A. Mesa. (2002) Clinical and scientific advances in the philadelphia-chromosome negative chronic myeloproliferative disorders. International Journal of Hematology 76:S2, pages 193-203.
Crossref
Crossref
Ming Fang, Samina Agha, Leslie Lockridge, Ronald Lee, Joseph P. Cleary & Eric M. Mazur. (2001) Medical Management of a Large Aortic Thrombus in a Young Woman With Essential Thrombocythemia. Mayo Clinic Proceedings 76:4, pages 427-431.
Crossref
Crossref
J Briere & F Guilmin. (2001) Management of patients with essential thrombocythemia: current concepts and perspectives. Pathologie Biologie 49:2, pages 178-183.
Crossref
Crossref
J Thiele & H.M Kvasnicka. (2001) Clinicopathology and histochemistry on bone marrow biopsies in chronic myeloproliferative disorders – a clue to diagnosis and classification. Pathologie Biologie 49:2, pages 140-147.
Crossref
Crossref
Randi, Putti, Fabris, Sainati, Zanesco & Girolami. (2001) Features of essential thrombocythaemia in childhood: a study of five children. British Journal of Haematology 108:1, pages 86-89.
Crossref
Crossref
Otto Braun-Falco, Gerd Plewig, Helmut H. Wolff & Walter H. C. BurgdorfOtto Braun-Falco, Gerd Plewig, Helmut H. Wolff & Walter H. C. Burgdorf. 2000. Dermatology. Dermatology
955
980
.
M. Griesshammer, M. Bangerter, T. Sauer, R. Wennauer, L. Bergmann & H. Heimpel. (2001) Aetiology and clinical significance of thrombocytosis: analysis of 732 patients with an elevated platelet count. Journal of Internal Medicine 245:3, pages 295-300.
Crossref
Crossref
Jan Jacques Michiels. (2016) Normal Life Expectancy and Thrombosis-Free Survival in Aspirin Treated Essential Thrombocythemia. Clinical and Applied Thrombosis/Hemostasis 5:1, pages 30-36.
Crossref
Crossref
Jean Briere & Nahed El-Kassar. (1998) 5 Clonality markers in polycythaemia and primary thrombocythaemia. Bailli?re's Clinical Haematology 11:4, pages 787-801.
Crossref
Crossref
Ming Hou, Jan Carneskog, Ulf‐Henrik Mellqvist, Dick Stockelberg, Martin Hedberg, Hans Wadenvik & Jack Kutti. (2009) Impact of endogenous thrombopoietin levels on the differential diagnosis of essential thrombocythaemia and reactive thrombocytosis. European Journal of Haematology 61:2, pages 119-122.
Crossref
Crossref
Jan Carneskog, Jack Kutti, Hans Wadenvik, Per-Arne Lundberg & Göran Lindstedt. (2009) Plasma erythropoietin by high-detectability immunoradiometric assay in untreated and treated patients with polycythaemia vera and essential thrombocythaemia. European Journal of Haematology 60:5, pages 278-282.
Crossref
Crossref
Eva LengfelderAndreas HochhausUrsula KronawitterDietrich HöcheWolfgang QueisserMichaela Jahn‐EderRolf BurkhardtAndreas ReiterHassan Ansari & Rüdiger Hehlmann. (2001)
Should a platelet limit of 600 × 10
9
/l be used as a diagnostic criterion in essential thrombocythaemia? An analysis of the natural course including early stages
. British Journal of Haematology 100:1, pages 15-23.
Crossref
Crossref
Jean Briere, Jean-Jacques Kiladjian & Edith Peynaud-Debayle. (1997) 4 Megakaryocytes and platelets in myeloproliferative disorders. Baillière's Clinical Haematology 10:1, pages 65-88.
Crossref
Crossref